"Speaking of Vitiligo..."

World Vitiligo Day, June 25th, is a day to raise awareness about the vitiligo, advocate for people with it, and foster a strong sense of community.

Vitiligo understanding & support. Learn about vitiligo & how to show support on World Vitiligo Day.

JAK inhibitors are a medications that show promise in treating vitiligo by interrupting the immune system signals that attack melanocytes.

Vitiligo research advances! UMass Chan's VCORT Symposium brings together experts for breakthroughs in treatment and cures.

A an act requiring full health insurance coverage for individuals with vitiligo that has been proposed by Reps Rob Consalvo and John J. Lawn, Jr.

Dr. John Harris discusses breakthroughs in vitiligo and how they've helped advance treatment options for many autoimmune diseases

Opzelura was already approved last September, 2021, for a disease called atopic dermatitis, or eczema, so you may have already seen it in the pharmacy. But most couldn’t get it covered by insurance for vitiligo because it wasn’t approved for it, and so NOW IT IS!

Treatment options for vitiligo remain limited. A new device is testing the effectiveness in repigmentation of stable vitiligo depigmented areas.

I’ve recently received many requests for an update on the new ruxolitinib cream to treat vitiligo. To remind everyone, we initially reported that oral ruxolitinib, a Janus Kinase inhibitor initially approved to treat a type of blood cancer, reversed disease in a patient with vitiligo.

Amit G. Pandya, MD is Staff Dermatologist at Palo Alto Medical Foundation. He is also a Clinical Professor, Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX.